Symbyax
NDC Package 0002-3232-30

The code 0002-3232-30 identifies a specific commercial package of 30 capsule in 1 bottle of Symbyax, labeled by Eli Lilly And Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eli Lilly And Company on December 24, 2003. The current certification is valid through January 31, 2022.

This medication is a combination of 2 drugs, olanzapine (an antipsychotic drug) and fluoxetine (a selective serotonin reuptake inhibitor-SSRI). It is used to treat a certain type of mental/mood disorder (depression associated with bipolar disorder). It is also used to treat depression that has not responded to other medications. This medication may help you sleep, improve your mood, improve your concentration, and decrease nervousness. It works by helping to restore the balance of certain natural substances in the brain (neurotransmitters). Talk to the doctor about the risks and benefits of treatment (especially when used in teenagers). See also Precautions section.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002323230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.